Cardinal Health margins, shrs could rise-Barron's

NEW YORK Nov 8 (Reuters) - Shares of Cardinal Health (CAH.N), the No. 2 U.S. drug distributor, should continue climbing, Barron's magazine said on Sunday.

Cardinal is up 19 percent since it spun off its medical technology unit, CareFusion (CFN.N), but its stock has greater potential to rise in price compared with that of rivals McKesson (MCK.N) and AmerisourceBergen (ABC.N).

The stock could rally into the low $40s per share, the paper said, as Cardinal management focuses its attention on boosting profit margins in pharmaceuticals distribution. Sales could also rise as the economy improves and more generics drugs are introduced.

(Reporting by Joseph A. Giannone; Editing Bernard Orr)